Avicanna Expands Medical Cannabis Integration with MyMedi.ca Healthcare Program
Event summary
- Avicanna launched MyMedi.ca Integrated Healthcare Program on September 9, 2026, to integrate medical cannabis care into Canadian healthcare institutions.
- The program extends access to a focused medical cannabis formulary, pharmacist-led patient support, and healthcare provider treatment planning.
- Building on the Sunnybrook Odette Cancer Centre pilot, the program aims to address the gap in medically guided cannabis care.
- Only 18% of Canadians using cannabis for medical purposes do so with a healthcare professional's guidance, per Health Canada's 2024 survey.
The big picture
Avicanna's MyMedi.ca program targets a critical gap in Canada's medical cannabis landscape, where most users lack professional guidance. The initiative aligns with broader trends toward integrating alternative therapies into mainstream healthcare, potentially setting a precedent for other biopharmaceutical companies. Success will depend on healthcare provider adoption and insurer support, which could significantly expand patient access and treatment outcomes.
What we're watching
- Adoption Pace
- How quickly Canadian hospitals and clinics will integrate the MyMedi.ca program into their existing care models.
- Regulatory Alignment
- Whether Health Canada will further regulate or support medically guided cannabis care pathways.
- Market Expansion
- The pace at which Avicanna can expand the program beyond Canada into other international markets.